Upper gastrointestinal cancer incidence

There is 1 paper on upper gastrointestinal cancer incidence in aging research: 1 observational study in people. The newest story, Oct 31, 2026: “Positive stool tests linked to colon and rectal cancer risk”.

Disease

1 paper studies it1 more mentions it1 finding

1 new paper in 30 daysSee all 2

“FIT positivity was also associated with increased risk of upper gastrointestinal cancer incidence (double-positive HR=1.56, 95% CI: 1.27-1.93)”
Associations of fecal immunochemical test positivity with risks of cancer incidence and mortality: findings from a community-based screening program in Pudong New Area of Shanghai, ChinaFrontiers in oncology2026doi:10.3389/fonc.2026.1995452
  • Humans1

Associations

1

Fecal immunochemical test positivity

upin humans1HR 1.56

1 study
  1. Fecal immunochemical test positivity is associated with upper gastrointestinal cancer incidence in humans (Double-positive FIT versus negative FIT) (HR 1.56, 95% CI 1.27-1.93).

    “FIT positivity was also associated with increased risk of upper gastrointestinal cancer incidence (double-positive HR=1.56, 95% CI: 1.27-1.93)”

    HumansDouble-positive FIT versus negative FITMean follow-up of 6.7 yearsn = 427,560

    Positive stool tests linked to colon and rectal cancer risk

    Frontiers in oncology

More on Fecal immunochemical test positivity

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 1Nov 2026: 01 paper in 12 months
Frontiers in Oncology

Positive stool tests linked to colon and rectal cancer risk

Two positive tests were linked to higher colon and rectal cancer rates than negative tests, with a hazard ratio—a measure of relative rates—of 8.49.Two positive tests were linked to higher colon and rectal cancer rates than negative tests, with a hazard ratio—a measure of relative rates—of 8.49.

Accepted, not yet published: cohort · 427,560 peopleCancer